Worth reading
50Recurring
Scored from 3 of 6 sectionsDirection
Improvement
Direction inferred from the company’s description.Scale
21.4
％Wording
Definitive
How definitive the wording is.Results for this period
Third quarter2024年4月1日〜2024年12月31日Non-consolidated (standalone)Japanese GAAPNet Sales10,839¥ millionYear on year +21.4%
Operating profit623¥ millionYear on year +28.0%
Ordinary income582¥ millionYear on year +19.9%
Net income attributable to owners of the parent471¥ millionYear on year +32.3%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit.
Financial position at period-end
Total assets26,896¥ million
of which net assets 12,762 ¥ million
The shaded area represents net assets as a proportion of total assets. It is calculated from the two amounts reported by the company.
Regional salesCategory Domestic / Net Sales for the Current Period ¥5,297 million / Net sales in the same period of the previous year ¥4,716 million, Category Exports / Net Sales for the Current Period ¥5,541 million / Net sales in the same period of the previous year ¥4,209 million
Outlook and shareholder returns
Revision to Earnings ForecastNo change
Factors Behind Changes in Business Performance
半導体市況の回復による半導体関連材料の販売増加、前期より好調な機能性ポリマー原料の売上増加。アミノ酸関係は医薬用途・半導体関連用途、化成品関係は高分子材料・機能性ポリマー原料・医薬関連原料の輸出販売、医薬品関係は一部の原薬・原薬中間体の販売が好調。
Disclosure regarding the going concern assumption
No applicable matters (There are no applicable matters.)
Breakdown of extraordinary income (loss)Extraordinary income Insurance proceeds received ¥65 million / Extraordinary loss Loss on Disposal of Fixed Assets ¥55 million
Depreciation and amortization¥745 million
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Non-consolidated (standalone) |
| Period Covered | 2024年4月1日〜2024年12月31日 |
| Net Sales | ¥10,839 million (YoY +21.4%) |
| Operating profit | ¥623 million (YoY +28.0%) |
| Ordinary income | ¥582 million (YoY +19.9%) |
| Profit attributable to owners of the parent | ¥471 million (YoY +32.3%) |
| Total assets | ¥26,896 million |
| Net assets | ¥12,762 million |
| Revision to Earnings Forecast | No change |
| Regional sales | Category Domestic / Net Sales for the Current Period ¥5,297 million / Net sales in the same period of the previous year ¥4,716 million, Category Exports / Net Sales for the Current Period ¥5,541 million / Net sales in the same period of the previous year ¥4,209 million |
| Depreciation and amortization | ¥745 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Insurance proceeds received ¥65 million / Extraordinary loss Loss on Disposal of Fixed Assets ¥55 million |
| Disclosure regarding the going concern assumption | No applicable matters (There are no applicable matters.) |
| Factors Behind Changes in Business Performance | 半導体市況の回復による半導体関連材料の販売増加、前期より好調な機能性ポリマー原料の売上増加。アミノ酸関係は医薬用途・半導体関連用途、化成品関係は高分子材料・機能性ポリマー原料・医薬関連原料の輸出販売、医薬品関係は一部の原薬・原薬中間体の販売が好調。 |
Items this document does not state (22)
Net income per shareOperating MarginEquity ratioCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodFull-year earnings forecastAnnual Dividend ForecastPayout ratioShareholder Return PolicySegment revenueSegment profitOrders received and order backlogImpairment lossChange in accounting policyChanges in the scope of consolidationMaterial subsequent eventsAvailability of Supplementary Financial Results MaterialsAvailability of Financial Results BriefingIssued Shares at Period-EndTreasury Shares at Period-End
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.半導体市況の回復により半導体関連材料の売上が増加したほか、前期より好調な機能性ポリマー原料の売上が増加したため。営業利益は売上高の増加に伴い増加した。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.